company-logo

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Taro Pharmaceutical Industries Dividend Announcement

Taro Pharmaceutical Industries announced a annually dividend of $12.86 per ordinary share which will be made payable on 2018-12-28. Ex dividend date: 2018-12-10
Taro Pharmaceutical Industries's trailing twelve-month (TTM) dividend yield is -%

Taro Pharmaceutical Industries Dividend History

Ex-Div dateDividend amountDividend typePay date
2018-12-10$12.86annually2018-12-28

Taro Pharmaceutical Industries Dividend per year

Taro Pharmaceutical Industries Dividend Yield

Taro Pharmaceutical Industries current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Taro Pharmaceutical Industries stock? Use our calculator to estimate your expected dividend yield:

Taro Pharmaceutical Industries Financial Ratios

P/E ratio29.99
PEG ratio0.82
P/B ratio0.90
ROE3.05%
Payout ratio0.00%
Current ratio3.61
Quick ratio2.93
Cash Ratio1.00

Taro Pharmaceutical Industries Dividend FAQ

Does Taro Pharmaceutical Industries stock pay dividends?
Taro Pharmaceutical Industries does not currently pay dividends to its shareholders.
Has Taro Pharmaceutical Industries ever paid a dividend?
No, Taro Pharmaceutical Industries has no a history of paying dividends to its shareholders. Taro Pharmaceutical Industries is not known for its dividend payments.
Why doesn't Taro Pharmaceutical Industries pay dividends?
There are several potential reasons why Taro Pharmaceutical Industries would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Taro Pharmaceutical Industries ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Taro Pharmaceutical Industries has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Taro Pharmaceutical Industries a dividend aristocrat?
Taro Pharmaceutical Industries is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Taro Pharmaceutical Industries a dividend king?
Taro Pharmaceutical Industries is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Taro Pharmaceutical Industries a dividend stock?
No, Taro Pharmaceutical Industries is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Taro Pharmaceutical Industries stocks?
To buy Taro Pharmaceutical Industries you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Taro Pharmaceutical Industries stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.